A KRAS-responsive long non-coding RNA controls microRNA processing
Wild-type KRAS amplification is known to induce KRAS activation in cancer leading to poor prognostic outcomes. Here the authors identify a KRAS-responsive lncRNA, KIMAT1 that maintains KRAS signalling in lung cancer, suggesting that its targeting may prevent KRAS-driven tumourigenesis.
Enregistré dans:
Auteurs principaux: | Lei Shi, Peter Magee, Matteo Fassan, Sudhakar Sahoo, Hui Sun Leong, Dave Lee, Robert Sellers, Laura Brullé-Soumaré, Stefano Cairo, Tiziana Monteverde, Stefano Volinia, Duncan D. Smith, Gianpiero Di Leva, Francesca Galuppini, Athanasios R. Paliouras, Kang Zeng, Raymond O’Keefe, Michela Garofalo |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/befd75df391041c7bcbc529acaf3af0c |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
The KRAS-variant and miRNA expression in RTOG endometrial cancer clinical trials 9708 and 9905.
par: Larissa J Lee, et autres
Publié: (2014) -
The lncRNA MALAT1 acts as a competing endogenous RNA to regulate KRAS expression by sponging miR-217 in pancreatic ductal adenocarcinoma
par: Pingping Liu, et autres
Publié: (2017) -
A potent KRAS macromolecule degrader specifically targeting tumours with mutant KRAS
par: Nicolas Bery, et autres
Publié: (2020) -
The microRNA analysis portal is a next-generation tool for exploring and analyzing miRNA-focused data in the literature
par: Stefano Pirrò, et autres
Publié: (2021) -
Suppression of KRas-mutant cancer through the combined inhibition of KRAS with PLK1 and ROCK
par: Jieqiong Wang, et autres
Publié: (2016)